Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.745 USD | +3.20% | +1.48% | +17.60% |
05-09 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
05-09 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.60% | 37.5M | |
+40.29% | 723B | |
+34.28% | 595B | |
-3.74% | 369B | |
+20.32% | 332B | |
+2.90% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.09% | 168B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Transcript : VYNE Therapeutics Inc., 2020 Earnings Call, Mar 04, 2021